The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global In Situ Hybridization (ISH) Market Research Report 2024

Global In Situ Hybridization (ISH) Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1713702

No of Pages : 88

Ask Your Query

Synopsis

In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs).

Global In Situ Hybridization (ISH) market is projected to reach US$ 1290.1 million in 2029, increasing from US$ 968.1 million in 2022, with the CAGR of 4.1% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole In Situ Hybridization (ISH) market research.

Increase in incidence of chronic diseases, coupled with need for rapid diagnostic techniques, is contributing to the increase in adoption of ISH.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global In Situ Hybridization (ISH) market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company (Partial List):

  •     Thermo Fisher Scientific
  •     Leica BiosystemsNussloch GmbH
  •     BIOVIEW
  •     Agilent Technologies
  •     Merck KGaA
  •     PerkinElmer Inc.
  •     Bio-Rad Laboratories Inc.
  •     NeoGenomics Laboratories Inc.
  •     Advanced Cell Diagnostics Inc.
  •     Oxford Gene Technology

Segment by Type

  •     Instruments
  •     Kits & Probes
  •     Software
  •     Services

Segment by Application

  •     Cancer
  •     Cytogenetics
  •     Developmental Biology
  •     Infectious Diseases
  •     Others

By Region

  •  North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

 

The In Situ Hybridization (ISH) report covers below items:.

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

 

 1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global In Situ Hybridization (ISH) Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Instruments
        1.2.3 Kits & Probes
        1.2.4 Software
        1.2.5 Services
    1.3 Market by Application
        1.3.1 Global In Situ Hybridization (ISH) Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Cancer
        1.3.3 Cytogenetics
        1.3.4 Developmental Biology
        1.3.5 Infectious Diseases
        1.3.6 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered

 2 Global Growth Trends
    2.1 Global In Situ Hybridization (ISH) Market Perspective (2018-2029)
    2.2 In Situ Hybridization (ISH) Growth Trends by Region
        2.2.1 Global In Situ Hybridization (ISH) Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 In Situ Hybridization (ISH) Historic Market Size by Region (2018-2023)
        2.2.3 In Situ Hybridization (ISH) Forecasted Market Size by Region (2024-2029)
    2.3 In Situ Hybridization (ISH) Market Dynamics
        2.3.1 In Situ Hybridization (ISH) Industry Trends
        2.3.2 In Situ Hybridization (ISH) Market Drivers
        2.3.3 In Situ Hybridization (ISH) Market Challenges
        2.3.4 In Situ Hybridization (ISH) Market Restraints

 3 Competition Landscape by Key Players
    3.1 Global Top In Situ Hybridization (ISH) Players by Revenue
        3.1.1 Global Top In Situ Hybridization (ISH) Players by Revenue (2018-2023)
        3.1.2 Global In Situ Hybridization (ISH) Revenue Market Share by Players (2018-2023)
    3.2 Global In Situ Hybridization (ISH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by In Situ Hybridization (ISH) Revenue
    3.4 Global In Situ Hybridization (ISH) Market Concentration Ratio
        3.4.1 Global In Situ Hybridization (ISH) Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by In Situ Hybridization (ISH) Revenue in 2022
    3.5 In Situ Hybridization (ISH) Key Players Head office and Area Served
    3.6 Key Players In Situ Hybridization (ISH) Product Solution and Service
    3.7 Date of Enter into In Situ Hybridization (ISH) Market
    3.8 Mergers & Acquisitions, Expansion Plans

 4 In Situ Hybridization (ISH) Breakdown Data by Type
    4.1 Global In Situ Hybridization (ISH) Historic Market Size by Type (2018-2023)
    4.2 Global In Situ Hybridization (ISH) Forecasted Market Size by Type (2024-2029)

 5 In Situ Hybridization (ISH) Breakdown Data by Application
    5.1 Global In Situ Hybridization (ISH) Historic Market Size by Application (2018-2023)
    5.2 Global In Situ Hybridization (ISH) Forecasted Market Size by Application (2024-2029)

 6 North America
    6.1 North America In Situ Hybridization (ISH) Market Size (2018-2029)
    6.2 North America In Situ Hybridization (ISH) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America In Situ Hybridization (ISH) Market Size by Country (2018-2023)
    6.4 North America In Situ Hybridization (ISH) Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada

 7 Europe
    7.1 Europe In Situ Hybridization (ISH) Market Size (2018-2029)
    7.2 Europe In Situ Hybridization (ISH) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe In Situ Hybridization (ISH) Market Size by Country (2018-2023)
    7.4 Europe In Situ Hybridization (ISH) Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries

 8 Asia-Pacific
    8.1 Asia-Pacific In Situ Hybridization (ISH) Market Size (2018-2029)
    8.2 Asia-Pacific In Situ Hybridization (ISH) Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific In Situ Hybridization (ISH) Market Size by Region (2018-2023)
    8.4 Asia-Pacific In Situ Hybridization (ISH) Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia

 9 Latin America
    9.1 Latin America In Situ Hybridization (ISH) Market Size (2018-2029)
    9.2 Latin America In Situ Hybridization (ISH) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America In Situ Hybridization (ISH) Market Size by Country (2018-2023)
    9.4 Latin America In Situ Hybridization (ISH) Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil

 10 Middle East & Africa
    10.1 Middle East & Africa In Situ Hybridization (ISH) Market Size (2018-2029)
    10.2 Middle East & Africa In Situ Hybridization (ISH) Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa In Situ Hybridization (ISH) Market Size by Country (2018-2023)
    10.4 Middle East & Africa In Situ Hybridization (ISH) Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE

 11 Key Players Profiles
    11.1 Thermo Fisher Scientific
        11.1.1 Thermo Fisher Scientific Company Detail
        11.1.2 Thermo Fisher Scientific Business Overview
        11.1.3 Thermo Fisher Scientific In Situ Hybridization (ISH) Introduction
        11.1.4 Thermo Fisher Scientific Revenue in In Situ Hybridization (ISH) Business (2018-2023)
        11.1.5 Thermo Fisher Scientific Recent Development
    11.2 Leica BiosystemsNussloch GmbH
        11.2.1 Leica BiosystemsNussloch GmbH Company Detail
        11.2.2 Leica BiosystemsNussloch GmbH Business Overview
        11.2.3 Leica BiosystemsNussloch GmbH In Situ Hybridization (ISH) Introduction
        11.2.4 Leica BiosystemsNussloch GmbH Revenue in In Situ Hybridization (ISH) Business (2018-2023)
        11.2.5 Leica BiosystemsNussloch GmbH Recent Development
    11.3 BIOVIEW
        11.3.1 BIOVIEW Company Detail
        11.3.2 BIOVIEW Business Overview
        11.3.3 BIOVIEW In Situ Hybridization (ISH) Introduction
        11.3.4 BIOVIEW Revenue in In Situ Hybridization (ISH) Business (2018-2023)
        11.3.5 BIOVIEW Recent Development
    11.4 Agilent Technologies
        11.4.1 Agilent Technologies Company Detail
        11.4.2 Agilent Technologies Business Overview
        11.4.3 Agilent Technologies In Situ Hybridization (ISH) Introduction
        11.4.4 Agilent Technologies Revenue in In Situ Hybridization (ISH) Business (2018-2023)
        11.4.5 Agilent Technologies Recent Development
    11.5 Merck KGaA
        11.5.1 Merck KGaA Company Detail
        11.5.2 Merck KGaA Business Overview
        11.5.3 Merck KGaA In Situ Hybridization (ISH) Introduction
        11.5.4 Merck KGaA Revenue in In Situ Hybridization (ISH) Business (2018-2023)
        11.5.5 Merck KGaA Recent Development
    11.6 PerkinElmer Inc.
        11.6.1 PerkinElmer Inc. Company Detail
        11.6.2 PerkinElmer Inc. Business Overview
        11.6.3 PerkinElmer Inc. In Situ Hybridization (ISH) Introduction
        11.6.4 PerkinElmer Inc. Revenue in In Situ Hybridization (ISH) Business (2018-2023)
        11.6.5 PerkinElmer Inc. Recent Development
    11.7 Bio-Rad Laboratories Inc.
        11.7.1 Bio-Rad Laboratories Inc. Company Detail
        11.7.2 Bio-Rad Laboratories Inc. Business Overview
        11.7.3 Bio-Rad Laboratories Inc. In Situ Hybridization (ISH) Introduction
        11.7.4 Bio-Rad Laboratories Inc. Revenue in In Situ Hybridization (ISH) Business (2018-2023)
        11.7.5 Bio-Rad Laboratories Inc. Recent Development
    11.8 NeoGenomics Laboratories Inc.
        11.8.1 NeoGenomics Laboratories Inc. Company Detail
        11.8.2 NeoGenomics Laboratories Inc. Business Overview
        11.8.3 NeoGenomics Laboratories Inc. In Situ Hybridization (ISH) Introduction
        11.8.4 NeoGenomics Laboratories Inc. Revenue in In Situ Hybridization (ISH) Business (2018-2023)
        11.8.5 NeoGenomics Laboratories Inc. Recent Development
    11.9 Advanced Cell Diagnostics Inc.
        11.9.1 Advanced Cell Diagnostics Inc. Company Detail
        11.9.2 Advanced Cell Diagnostics Inc. Business Overview
        11.9.3 Advanced Cell Diagnostics Inc. In Situ Hybridization (ISH) Introduction
        11.9.4 Advanced Cell Diagnostics Inc. Revenue in In Situ Hybridization (ISH) Business (2018-2023)
        11.9.5 Advanced Cell Diagnostics Inc. Recent Development
    11.10 Oxford Gene Technology
        11.10.1 Oxford Gene Technology Company Detail
        11.10.2 Oxford Gene Technology Business Overview
        11.10.3 Oxford Gene Technology In Situ Hybridization (ISH) Introduction
        11.10.4 Oxford Gene Technology Revenue in In Situ Hybridization (ISH) Business (2018-2023)
        11.10.5 Oxford Gene Technology Recent Development

 12 Analyst's Viewpoints/Conclusions

 13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock